RCAN1 in the inverse association between Alzheimer’s disease and cancer

Qiang Fu; Yili Wu

doi:10.18632/oncotarget.23094

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers: Gerotarget (Focus on Aging):

RCAN1 in the inverse association between Alzheimer’s disease and cancer

Qiang Fu and Yili Wu _

PDF | HTML | How to cite

Oncotarget. 2018; 9:54-66. https://doi.org/10.18632/oncotarget.23094

Metrics: PDF 2016 views | HTML 3725 views | ?

Abstract

Qiang Fu1 and Yili Wu2,3,4

1 Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China

2 Department of Psychiatry, Jining Medical University, Jining, Shandong, China

3 Shandong Key Laboratory of Behavioral Medicine, Jining, Shandong, China

4 Collaborative Innovation Center for Birth Defect Research and Transformation of Shandong Province, Jining, Shandong, China.

Correspondence to:

Yili Wu, email:

Keywords: RCAN1; Alzheimer’s disease; cancer; inverse association; Gerotarget

Received: June 29, 2017 Accepted: November 17, 2017 Published: December 11, 2017

Abstract

The inverse association between Alzheimer’s disease (AD) and cancer has been reported in several population-based studies although both of them are age-related disorders. However, molecular mechanisms of the inverse association remain elusive. Increased expression of regulator of calcineurin 1 (RCAN1) promotes the pathogenesis of AD, while it suppresses cancer growth and progression in many types of cancer. Moreover, aberrant RCAN1 expression is detected in both AD and various types of cancer. It suggests that RCAN1 may play a key role in the inverse association between AD and cancer. In this article, we aim to review the role of RCAN1 in the inverse association and discuss underlying mechanisms, providing an insight into developing a novel approach to treat AD and cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23094

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers: Gerotarget (Focus on Aging):

RCAN1 in the inverse association between Alzheimer’s disease and cancer

Abstract